stockportfolio.pro
Stocks / CNMD vs EYPT
CNMD vs EYPT
CONMED Corporation and EyePoint, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| CONMED Corporation (CNMD) | EyePoint, Inc. (EYPT) | |
|---|---|---|
| Market cap | $1.1B | $1.0B |
| Revenue (latest FY) | $1.37B | $31.37M |
| Net income (latest FY) | $47.05M | $-231.96M |
| Revenue growth (5y CAGR) | 9.8% | -1.8% |
| Net margin | 3.4% | -739.4% |
| Return on equity | 4.6% | -75.8% |
| P/E ratio | 20.4 | — |
| Dividend yield | 2.2% | — |
| Profitable years (of last 10) | 9 | 0 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open CNMD — free Open EYPT — freeFrequently asked questions
Which is bigger, CNMD or EYPT?
CONMED Corporation is larger by market capitalization — $1.1B versus $1.0B.
Which grows faster, CNMD or EYPT?
Over the last five fiscal years, CONMED Corporation grew revenue faster — 9.8%/yr versus -1.8%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.